
The concept of passive and active targeting of solid zzso with zzso administered particulate and zzso carriers is an attractive one that has received considerable attention and promising results have emerged from such attempts at the clinical zzso zzso and zzso drug carriers have the capability to deliver from zzso to zzso more drug to solid zzso compared with the administered drug in its free form, and it is through the altered zzso and zzso of the zzso drugs relative to free drugs that zzso drug-induced toxicity is dramatically zzso 

It is the intention of this article to examine the role of selected particulate and zzso entities as carriers of zzso drugs and their ability to target different components of solid zzso following the intravenous route of injection, and release their cargo in a zzso form at levels that exceed the minimum zzso zzso 

The authors of this paper have focused on carrier zzso zzso of single and multiple injections, and new toxicity issues that may arise from different dosing schedules and dose zzso as well as from the carrier zzso zzso factors regulating particulate and zzso transport into zzso zzso arrangements of zzso zzso zzso vascular zzso zzso hypertension and zzso zzso and zzso and zzso factors controlling drug release from zzso carriers (the zzso zzso 

zzso drug carriers can passively target solid zzso but achieving therapeutic responses involves zzso processes that control carrier transport into zzso and zzso factors regulating drug release from zzso carriers and maintaining free drug levels above the minimum zzso zzso It is conceivable that future sophistication in zzso targeting and the outcome of end results will depend on an improved understanding of zzso biology and biological zzso as well as advances in carrier design and zzso 

